Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Cash flows from operating activities:    
Net income $ 123,602 $ 107,774
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 67,018 66,117
Non-cash interest expense, net of amortization of premium 5,442 10,647
Provision for doubtful accounts 11,410 6,208
Amortization of deferred income related to equity method investment (694) (694)
Loss on extinguishment of debt and credit facilities, net 0 9,971
(Gain) loss on unconsolidated entity investments, net (1,345) 422
Dividend received from unconsolidated entity investment 9,674 0
Loss on disposal of assets 124 0
Share-based payment expense 14,518 14,951
Deferred income taxes 83,631 1,572
Other non-cash purchase price adjustments (70,459) (73,956)
Changes in operating assets and liabilities:    
Accounts receivable (13,143) (12,838)
Receivables from distributors 1,663 (11,220)
Inventory 5,242 (80)
Related party assets 26 8,347
Prepaid expenses and other current assets (51,815) (65,753)
Other long-term assets 1,730 8,256
Accounts payable and accrued expenses (97,537) (96,859)
Accrued interest 31,054 7,157
Deferred revenue 47,480 56,182
Related party liabilities 5,891 2,239
Other long-term liabilities (4,597) 1,505
Net cash provided by operating activities 168,915 39,948
Cash flows from investing activities:    
Additions to property and equipment (26,434) (25,187)
Net cash used in investing activities (26,434) (25,187)
Cash flows from financing activities:    
Proceeds from exercise of stock options 10,946 22,765
Payment of premiums on redemption of debt 0 (6,602)
Repayment of long-term borrowings (1,933) (58,338)
Common stock repurchased and retired (465,712) 0
Net cash used in financing activities (456,699) (42,175)
Net decrease in cash and cash equivalents (314,218) (27,414)
Cash and cash equivalents at beginning of period 520,945 773,990
Cash and cash equivalents at end of period 206,727 746,576
Cash paid during the period for:    
Interest, net of amounts capitalized 2,928 56,129
Non-cash investing and financing activities:    
Conversion of Series B preferred stock to common stock 1,293 0
Treasury stock not yet retired 27,923 0
Conversion of 7% Exchangeable Notes to common stock, net of debt issuance and deferred financing costs $ 45,097 $ 0